McKesson, AmerisourceBergen and Cardinal Health’s stock each increased 2 to 3 percent April 16. Walgreens Boots Alliance and CVS Health’s stock both jumped about 5 percent.
Amazon’s retreat from drug distribution stems from its inability to convince hospitals to follow different purchasing processes for pharmaceuticals, unnamed sources told CNBC. Instead, the Amazon Business unit will focus on selling less sensitive medical supplies to smaller hospitals and clinics.
Amazon declined Reuters‘ request for comment.
More articles on supply chain:
Bloomberg: Why generic medications may disappear
Taking the Operating Room Supply Chain Processes from ‘Necessary Evil’ to ‘Essential Ally’
High drug prices worry 83% of Americans: This is CVS’ new solution
